CONTEXT: Erectile dysfunction (ED) after radical prostatectomy (RP) has a significant
negative impact on a patient's health-related quality of life. Phosphodiesterase type 5 …

The pathophysiology of erectile dysfunction after radical prostatectomy (RP) is believed to
include neuropraxia, which leads to temporarily reduced oxygenation and subsequent …

Metabolic syndrome (MetS) and benign prostatic hyperplasia (BPH)/lower urinary tract
symptoms (LUTS) are often associated. One of their common denominators is …

Introduction In humans, prostate phosphodiesterase type 5 inhibitors (PDE5) expression
was prominently localized in the endothelial and smooth muscle cells of the vascular bed …

Introduction Prostate cancer is common and is being diagnosed in younger men now
compared with two decades ago. Long-term functional outcomes are of significant …

Background Penile rehabilitation, defined as the use of any drug or device at or after radical
prostatectomy to maximize erectile function recovery, is commonly used for post …

Introduction Although the literature of the positive effects of penile low intensity
extracorporeal shockwave therapy is meanwhile substantial, there are substantial …

The treatment for erectile dysfunction (ED) was revolutionized with the development of
phosphodiesterase type 5 (PDE5) inhibitors. Tadalafil (Cialis®; Eli Lilly and Company …

Introduction Radical prostatectomy (RP) is associated with erectile dysfunction (ED). A
single, placebo-controlled, human study has assessed the effects of regular sildenafil use …

Purpose: We studied adjuvant daily sildenafil citrate during and after radiotherapy for
prostate cancer for erectile function preservation. Materials and Methods: We performed a …